Repeated Mechanical Endovascular Thrombectomy for Recurrent Large Vessel Occlusion: A Multicenter Experience

Ghada A Mohamed1, Hassan Aboul Nour1, Raul G Nogueira2

  • 1Department of Neurology, Henry Ford Hospital, Detroit, MI (G.A.M., H.A.N., L.S., D.M., A.B.C.).

Stroke
|April 29, 2021
PubMed
Abstract

Insights

Nearly 2% of patients undergoing mechanical thrombectomy (MT) experience recurrent large vessel occlusion (LVO) stroke, often in the same artery. Repeat MT is safe and effective, with 30% of patients achieving good outcomes.

Area of Science:

  • Neurology
  • Interventional Neuroradiology
  • Stroke Medicine

Background:

  • Mechanical thrombectomy (MT) is the standard treatment for large vessel occlusion (LVO) stroke.
  • Data on the frequency and outcomes of repeat MT (rMT) for recurrent LVO is limited.

Purpose of the Study:

  • To investigate the incidence and outcomes of repeat mechanical thrombectomy (rMT) in patients experiencing recurrent large vessel occlusion (LVO) stroke.

Main Methods:

  • Retrospective multicenter cohort study of 54 patients who underwent rMT across 6 US tertiary institutions (March 2016 - March 2020).
  • Analysis included procedural data, imaging, and modified Rankin Scale (mRS) outcomes at discharge.

Main Results:

  • 1.8% of 3059 MT patients underwent rMT; 65% of recurrent LVO occurred during the index hospitalization.
  • Recurrent LVO often involved previously treated arteries (59%), primarily the left MCA.
  • Successful recanalization (TICI 2b/3) was achieved in 94% of rMT procedures; 30% of patients had good outcomes (mRS ≤2), 50% had moderate-to-severe disability (mRS 3-5), and 20% died.

Conclusions:

  • Recurrent LVO after MT occurs in approximately 2% of patients, frequently affecting previously treated vessels during the same hospitalization.
  • Repeat MT is a safe and effective revascularization strategy.
  • Approximately 30% of patients undergoing rMT can expect a favorable outcome.